Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program (OTP) in 2023, overcoming numerous challenges whilst maintaining uninterrupted service to
Following the retirement of Curtis Ruhnau, PDL is pleased to announce the appointment of Amanda Galbraith as the new Director for NSW and the ACT.
Due to the impending retirement of Curtis Ruhnau, expressions of interest are invited by PDL for the position of Director for New South Wales (with
The PDL Director elections for the New South Wales and Australian Capital Territory seat as well as for Western Australia were held recently, with the
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.